You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chemoimmunotherapy

Showing 1 - 25 of 244
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced

Completed
  • Oral Cancer
  • PD-1 inhibitor+carboplatin+albumin-bound paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital
Nov 20, 2023

Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)

Recruiting
  • Neuroblastoma
  • Ganglioneuroblastoma
  • monoclonal antibodies GD2
  • Moscow, Russian Federation
    Research Institute of Pediatric Hematology, Oncology and Immunol
Oct 4, 2023

Glioblastoma Trial in Louisville (Pembrolizumab and Temozolomide)

Recruiting
  • Glioblastoma
  • Pembrolizumab and Temozolomide
  • Louisville, Kentucky
    James Graham Brown Cancer Ctr.
Jan 18, 2023

Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • CT/PET/WSI-based Deep Learning Signature
  • Zunyi, Guizhou, China
  • +2 more
Jun 27, 2023

Lymphoma, B-Cell Trial in San Antonio (R-Chop and Roflumilast)

Not yet recruiting
  • Lymphoma, B-Cell
  • R-Chop and Roflumilast
  • San Antonio, Texas
    Mays Cancer Center, UT Health San Antonio
Mar 31, 2023

ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction

Not yet recruiting
  • Non-small Cell Lung Cancer
  • NGS and ctDNA-MRD detection
  • Changsha, Hunan, China
    Department of Thoracic Surgery, Second Xiangya Hospital of Centr
Apr 18, 2023

Small Cell Lung Carcinoma Trial in Milano (Cyclic, 5-day calorie restriction, Atezolizumab)

Not yet recruiting
  • Small Cell Lung Carcinoma
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Jan 19, 2023

Stage I Colon Cancer, Stage II Colon Cancer, Stage III Colon Cancer Trial in Houston (Tecentriq 1200 MG in 20 ML Injection +

Not yet recruiting
  • Stage I Colon Cancer
  • +2 more
  • Tecentriq 1200 MG in 20 ML Injection + Capecitabine 1000 mg/m2 + Oxaliplatin 130 mg/m2
  • +2 more
  • Houston, Texas
    Baylor College of Medicine
May 22, 2023

NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Phase I - Mirdametinib - Level 1
  • +4 more
  • (no location specified)
Jul 7, 2023

Mature B-Cell Non-Hodgkin Lymphoma Trial (Obinutuzumab, Glofitamab, Rituximab)

Not yet recruiting
  • Mature B-Cell Non-Hodgkin Lymphoma
  • (no location specified)
Sep 6, 2022

Triple Negative Breast Cancer, Breast Cancer Trial in United States (Carboplatin, Docetaxel, Doxorubicin)

Recruiting
  • Triple Negative Breast Cancer
  • Breast Cancer
  • Fairway, Kansas
  • +5 more
Jan 26, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Leukemia
  • (no location specified)
Nov 30, 2022

Breast Cancer, Triple Negative Breast Cancer, Dietary Exposure Trial (Control diet (ARM A) or Fasting-Like Approach (FLA, ARM

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Control diet (ARM A) or Fasting-Like Approach (FLA, ARM B)
  • (no location specified)
Feb 28, 2023

Lymphoma, Large B-Cell, Diffuse Trial in Milan (NGR-hTNF, RITUXIMAB, Doxorubicin)

Completed
  • Lymphoma, Large B-Cell, Diffuse
  • Milan, Italy
    Ospedale San Raffaele
Aug 2, 2022

Squamous Cell Carcinoma of Head and Neck, Neoadjuvant Therapy, Resection Margin Trial in Wuhan (Reducing Excision Margins)

Active, not recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
  • Reducing Excision Margins
  • Wuhan, Hubei, China
    Zhanjie Zhang
Jul 11, 2022

Leukemia, Lymphoma Trial in Houston (Ofatumumab)

Active, not recruiting
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 9, 2022

Prostate Cancer Metastatic Trial in New York (REGN2810, Degarelix, Leuprolide Acetate)

Recruiting
  • Prostate Cancer Metastatic
  • New York, New York
    Columbia University Irving Medical Center
Mar 22, 2022

Extensive-stage Small-cell Lung Cancer, Liver Metastases Trial in Los Angeles, Ann Arbor (Bevacizumab)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Liver Metastases
  • Los Angeles, California
  • +2 more
Oct 18, 2022

ctDNA Testing Plus AI-based Pathology in Resectable LSCC

Recruiting
  • Lung Squamous Cell Carcinoma
  • WES and ctDNA detection
  • Changsha, Hunan, China
    Department of Thoracic Surgery, Second Xiangya Hospital of Centr
Mar 18, 2023

Advanced Triple Negative Breast Cancer Trial in Newport Beach (N-803, PD-L1 t-haNK, Sacituzumab Govitecan-Hziy)

Active, not recruiting
  • Advanced Triple Negative Breast Cancer
  • N-803
  • +3 more
  • Newport Beach, California
    Hoag Memorial Hospital
Mar 29, 2022

Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy Trial (neoadjuvant anti-PD-1 (Keytruda) plus chemo)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Neoadjuvant Chemoimmunotherapy
  • neoadjuvant anti-PD-1 (Keytruda) plus chemotherapy
  • (no location specified)
Feb 14, 2023

Stomach Tumors, Esophagogastric Junction Disorder, Neoadjuvant Therapy Trial in Shanghai (drug, radiation, procedure)

Recruiting
  • Stomach Neoplasms
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 3, 2021

Larynx Cancer, Hypopharyngeal Cancer Trial in Shanghai (procedure, radiation, drug)

Recruiting
  • Larynx Cancer
  • Hypopharyngeal Cancer
  • Surgery
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 9, 2023

Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

Completed
  • Lymphoid Leukemia
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin
Jan 30, 2023

Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy, Adjuvant Therapy Trial in Shanghai (Tislelizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai chest hospital
Sep 24, 2023